Digital treatment for adolescents with eating disorders
Evaluation of a Personalised Digital Treatment for Adolescents With Eating Disorders - An Open Feasibility Trial in Routine Care
This study is testing a personalized online treatment program for teenagers with eating disorders to see if it helps them improve over 10 weeks.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 15 Years to 18 Years |
| Sex | All |
| Sponsor | Haukeland University Hospital Academic / other |
| Locations | 3 sites (Bømlo, Vestland and 2 other locations) |
| Trial ID | NCT06306586 on ClinicalTrials.gov |
What this trial studies
This feasibility study aims to evaluate a personalized digital treatment for adolescents aged 15 to 18 with eating disorders. Participants will engage in a 10-week program that includes weekly therapist contact and complete self-report questionnaires at various intervals. The study will assess the feasibility of the intervention, identify which adolescents benefit most, and analyze the cost-benefit of the treatment. The research employs a Person-based approach to develop effective behavior change interventions tailored to the needs of the participants.
Who should consider this trial
Good fit: Ideal candidates are adolescents aged 15 to 18 diagnosed with specific eating disorders who have stable psychiatric treatment and internet access.
Not a fit: Patients with anorexia nervosa, bulimia nervosa, or severe psychological disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this digital treatment could provide accessible and effective support for adolescents struggling with eating disorders.
How similar studies have performed: Other studies have shown promising results with digital interventions for eating disorders, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: A. Diagnosed with F50.1 Atypical anorexia nervosa, F50.3 Atypical bulimia nervosa, F50.8 Other eating disorders, F50.9 Eating disorder, unspecified B. Age between 15 and 18 years. C. Stable dose of medication for a co-morbid psychiatric treatment for six weeks and who continue to meet study entry criteria. D. Internet access. E. Speaks and write Norwegian. Exclusion Criteria: A. Diagnosed with F50.0 Anorexia nervosa or F50.2 Bulimia nervosa B. Disorders of psychological development (F80-F89). C. Patients with avoidant restrictive food intake disorders (F50.82) D. Participants with a co-morbid medical condition or disorder known to influence eating or weight (i.e., pregnancy, cancer), psychotic disorders, acute suicidality, or substance abuse and/or substance dependence and severe depressive episode. E. Receiving inpatient- or face to face psychological treatment.
Where this trial is running
Bømlo, Vestland and 2 other locations
- Bømlo Kommune — Bømlo, Vestland, Norway (Withdrawn)
- Haukeland University Hospital — Bergen, Norway (Recruiting)
- Helse Fonna — Haugesund, Norway (Completed)
Study contacts
- Principal investigator: Tine Nordgreen, PhD — Division of Psychiatry, Haukeland University Hospital
- Study coordinator: Emilie Nordby, MA
- Email: emilie.sektnan.nordby@helse-bergen.no
- Phone: 55975000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.